Maimuna S. Majumder

Sukanya Krishna, Marie-Laure Charpignon, Maimuna Majumder

Substance overdose mortality in the United States claimed over 80,000 lives in 2023, with the COVID-19 pandemic exacerbating existing trends through healthcare disruptions and behavioral changes. Estimating excess mortality, defined as deaths beyond expected levels based on pre-pandemic patterns, is essential for understanding pandemic impacts and informing intervention strategies. However, traditional statistical methods like SARIMA assume linearity, stationarity, and fixed seasonality, which may not hold under structural disruptions. We present a systematic comparison of SARIMA against three deep learning (DL) architectures (LSTM, Seq2Seq, and Transformer) for counterfactual mortality estimation using national CDC data (2015-2019 for training/validation, 2020-2023 for projection). We contribute empirical evidence that LSTM achieves superior point estimation (17.08% MAPE vs. 23.88% for SARIMA) and better-calibrated uncertainty (68.8% vs. 47.9% prediction interval coverage) when projecting under regime change. We also demonstrate that attention-based models (Seq2Seq, Transformer) underperform due to overfitting to historical means rather than capturing emergent trends. Ourreproducible pipeline incorporates conformal prediction intervals and convergence analysis across 60+ trials per configuration, and we provide an open-source framework deployable with 15 state health departments. Our findings establish that carefully validated DL models can provide more reliable counterfactual estimates than traditional methods for public health planning, while highlighting the need for calibration techniques when deploying neural forecasting in high-stakes domains.

Saurav Ghosh, Prithwish Chakraborty, Bryan L. Lewis et al.

Real-time monitoring and responses to emerging public health threats rely on the availability of timely surveillance data. During the early stages of an epidemic, the ready availability of line lists with detailed tabular information about laboratory-confirmed cases can assist epidemiologists in making reliable inferences and forecasts. Such inferences are crucial to understand the epidemiology of a specific disease early enough to stop or control the outbreak. However, construction of such line lists requires considerable human supervision and therefore, difficult to generate in real-time. In this paper, we motivate Guided Deep List, the first tool for building automated line lists (in near real-time) from open source reports of emerging disease outbreaks. Specifically, we focus on deriving epidemiological characteristics of an emerging disease and the affected population from reports of illness. Guided Deep List uses distributed vector representations (ala word2vec) to discover a set of indicators for each line list feature. This discovery of indicators is followed by the use of dependency parsing based techniques for final extraction in tabular form. We evaluate the performance of Guided Deep List against a human annotated line list provided by HealthMap corresponding to MERS outbreaks in Saudi Arabia. We demonstrate that Guided Deep List extracts line list features with increased accuracy compared to a baseline method. We further show how these automatically extracted line list features can be used for making epidemiological inferences, such as inferring demographics and symptoms-to-hospitalization period of affected individuals.